Influenza is an acute respiratory infectious disease caused by influenza virus, which poses a serious risk to human health. People are generally susceptible to influenza virus. There is an international consensus that influenza vaccination is the most effective way to prevent and control influenza. In China, influenza vaccination is a non-immunization programme vaccine that is vaccinated voluntarily and at one’s own expense. In some regions, immunization policies are implemented for priority groups. In recent years, a number of health economic evaluations on influenza vaccination have been conducted both at home and abroad, especially for key and high-risk populations such as pregnant women, children, elderly people aged ≥60 years old, people suffering from one or more chronic diseases, and health care workers. This paper analyzed the current status of researches on health economic evaluation of influenza vaccination through collating relevant literatures published at home and abroad in recent years, so as to provide a scientific basis for the formulation of influenza vaccination strategies in China.